The anti-CD40L antibody treatment showed an improvement in the number of platelets in immune thrombocytopenic purpura but did not improve performance scores in systemic lupus erythematosus [11, 28, 69, 78]. The gene discussed is CD40LG; the disease is systemic lupus erythematosus.